相关实验视频

Updated: Jan 14, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

库马林-胺醇混合物:设计,合成和识别潜在的抗癌剂

C G Arya¹, Neethu Mariam Thomas¹, Munugala Chandrakanth¹

¹Department of Chemistry, National Institute of Technology Calicut, Kozhikode 673601, Kerala, India.

Bioorganic & medicinal chemistry letters

|October 20, 2025

概括

新的库马林-胺醇化合物对肺癌和乳腺癌细胞表现出强大的抗癌活性. 化合物6b特别有效,并显示出有利于未来药物开发的特性.

科学领域:

药用化学医学化学
有机合成有机合成
药理学药理学是指药理学的学科.

背景情况:

库马林和胺醇支架因其多样化的生物活动而闻名.
开发具有提高疗效和选择性的新型抗癌药物仍然是瘤学的关键挑战.

研究的目的:

设计和合成新型氨酸-胺醇结合物.
评估这些结合物对人类肺癌 (A549) 和乳腺癌 (MCF7) 细胞系的体外抗癌潜力.
研究最强效化合物的作用机制和药理动力学特性.

主要方法:

使用聚酸介导的凝结合成库马林-胺联合物 (6a-p).
使用A549和MCF7癌细胞系进行体外细胞毒性测定,确定IC50值.
在基分子对接研究中预测潜在的蛋白质标 (SK1,CDK2).
用ADMET分析来评估药物动力学特性.

主要成果:

大多数合成的结合物对A549和MCF7细胞系表现出显著的细胞毒性,IC50值低至0.85±0.07μM.
化合物6b表现出最高的强度,其IC50值为0.85 ± 0.07μM (A549) 和1.90 ± 0.08μM (MCF7).
化合物6b和6g对癌细胞具有选择性毒性,对Vero细胞无毒 (LD50 > 100μM).
分子对接建议SK1抑制6b和CDK2抑制6g.
对ADMET的分析表明,化合物6b具有有利的药理动力学特性.

结论:

合成的库马林-胺醇合物代表了一类有前途的抗癌药物.
化合物6b被确定为进一步抗癌药物开发的主要候选物,因为它具有强大和选择性的活性以及有利的药理动力学特征.
需要进一步的生物测试来验证预测的作用机制.

关键词:

在ADMET的预测中.它具有抗癌活性.西米达 (Benzimidazole) 是一种一种库马林是一种素.分子对接研究分子对接研究.

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...